CD37 CAR mRNA-LNP

Cat. No.: TDLD-0825-LD52

CD37 CAR mRNA-LNP

CD37 CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting CD37, serving as an excellent tool for investigating novel CAR-T cell therapies for B-cell malignancies, facilitating studies on targeted immune responses and tumor cell elimination mechanisms. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of CD37 CAR mRNA-LNP include evaluating CAR expression on engineered T cells and assessing their cytotoxic activity against CD37-positive cancer cell lines. Please note that this product is intended for research purposes only.